← Home
The Prof G Pod with Scott Galloway · June 4, 2026 · 47m

Why People Are Losing Faith in Healthcare

David Ricks

Scott Galloway is joined by David Ricks, Chair and CEO of Eli Lilly, to analyze the forces reshaping healthcare. Their conversation examines the rapid rise of GLP-1 drugs, the shifting landscape of obesity treatment, and the growing erosion of public trust in the American medical system. They also explore healthcare cost structures, the proliferation of unregulated peptides, the future of pharmaceutical innovation, and how artificial intelligence could transform drug discovery.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

•
GLP-1 Drugs and the Future of Obesity Treatment
Scott Galloway and David Ricks explore how GLP-1 medications are changing the way obesity is treated.
ClaudeChatGPTGemini
•
Why America's Healthcare System Faces a Crisis of Trust
They examine the factors driving a decline in public confidence in the U.S. healthcare system.
ClaudeChatGPTGemini
•
The Challenge of Unregulated Peptide Treatments
The discussion covers the risks posed by unregulated peptides being sold as weight-loss or wellness solutions.
ClaudeChatGPTGemini
•
Addiction as a Healthcare Challenge
Addiction is discussed alongside other healthcare issues, highlighting its role in the broader crisis of trust and cost.
ClaudeChatGPTGemini
•
Pharmaceutical Innovation and AI in Drug Discovery
They project how artificial intelligence could reshape the way new drugs are discovered and developed.
ClaudeChatGPTGemini
Was this useful?